| Year |
Citation |
Score |
| 2017 |
Ghonime MG, Jackson J, Shah A, Roth J, Li M, Saunders U, Coleman J, Gillespie GY, Markert JM, Cassady KA. Chimeric HCMV/HSV-1 and Δγ134.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory. Translational Oncology. 11: 86-93. PMID 29216507 DOI: 10.1016/J.Tranon.2017.10.005 |
0.551 |
|
| 2015 |
Shah AC, Minturn JE, Li Y, Belasco JB, Phillips PC, Kang TI, Cole KA, Waanders AJ, Pollack R, Didomenico C, Wildes C, Fisher MJ. Carboplatin Rechallenge After Hypersensitivity Reactions in Pediatric Patients With Low-Grade Glioma. Pediatric Blood & Cancer. PMID 26235452 DOI: 10.1002/Pbc.25697 |
0.314 |
|
| 2009 |
Shah AC, Parker JN, Shimamura M, Cassady KA. Spontaneous and Engineered Compensatory HSV Mutants that Counteract the Host Antiviral PKR Response. Viruses. 1: 510-22. PMID 21994558 DOI: 10.3390/V1030510 |
0.586 |
|
| 2007 |
Shah AC, Parker JN, Gillespie GY, Lakeman FD, Meleth S, Markert JM, Cassady KA. Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses. Gene Therapy. 14: 1045-54. PMID 17429445 DOI: 10.1038/Sj.Gt.3302942 |
0.62 |
|
| 2006 |
Shah AC, Price KH, Parker JN, Samuel SL, Meleth S, Cassady KA, Gillespie GY, Whitley RJ, Markert JM. Serial passage through human glioma xenografts selects for a Deltagamma134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors. Journal of Virology. 80: 7308-15. PMID 16840311 DOI: 10.1128/Jvi.00725-06 |
0.595 |
|
| 2003 |
Shah AC, Benos D, Gillespie GY, Markert JM. Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas. Journal of Neuro-Oncology. 65: 203-26. PMID 14682372 DOI: 10.1023/B:Neon.0000003651.97832.6C |
0.574 |
|
| Show low-probability matches. |